Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
This study aimed to investigate whether CYP3A4/5 genetic variants, together with clinical and patient factors, influence serum fentanyl and norfentanyl concentrations and their ratio in cancer pain patients receiving transdermal fentanyl.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Pharmacogenetics and Genomics |
| Vol/bind | 24 |
| Udgave nummer | 4 |
| Sider (fra-til) | 185-194 |
| Antal sider | 10 |
| ISSN | 1744-6872 |
| Status | Udgivet - 2014 |
Links
ID: 101829242